Finally, given the immunologic aspects of cancer and major surgery, research into how patient-specific factors (like baseline inflammatory status, use of steroids or immunosuppressants, and tumor-related inflammation) modulate CRP responses would be valuable. The gene discussed is CRP; the disease is neoplasm.